Regulations and Regulatory Advocacy

The Department of Health and Human Services Office for Civil Rights today published in the Federal Register its final rule concerning federal health care-related conscience protections applicable to programs funded or administered by HHS.
The Centers for Medicare & Medicaid Services May 16 released a final rule with the intent of lowering drug prices for beneficiaries enrolled in Medicare Advantage and Part D programs.
The Centers for Medicare & Medicaid Services recently released proposed guidelines around hospital co-location arrangements. The draft guidance seeks to clarify how CMS and state surveyors will evaluate co-location arrangements for compliance with the Medicare conditions of participation.
The Department of Health and Human Services (HHS) Office for Civil Rights May 2 issued a final rule concerning federal health care-related conscience protections applicable to programs funded or administered by HHS (e.g., Medicare, Medicaid or grant programs).
The Federal Trade Commission will hold a public workshop June 18 in Washington, D.C., to assess the impact of certificates of public advantage on health care prices, quality, access and innovation.
The Department of Health and Human Services today issued a final rule protecting certain statutory conscience rights in health care.
The Centers for Medicare & Medicaid Services today issued a final rule that eliminates 2014 regulatory text allowing states to reassign Medicaid payments to third parties on behalf of certain providers.
The Food and Drug Administration Friday approved the first generic naloxone nasal spray, an emergency treatment for opioid overdose intended for use in the community. Generic injectable naloxone products have been available for use in health care settings for years.
AHA provides input to CMS regarding potential future changes to the Centers for Medicare & Medicaid Services (CMS) hospital overall star ratings system.